Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Maguire, A.
Right arrow Articles by Moynihan, P.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maguire, A.
Right arrow Articles by Moynihan, P.J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

RAPID COMMUNICATION

Bioavailability of Fluoride in Drinking Water: a Human Experimental Study

A. Maguire*, F.V. Zohouri, J.C. Mathers, I.N. Steen, P.N. Hindmarch and P.J. Moynihan

Faculty of Medical Sciences, University of Newcastle, Framlington Place, Newcastle upon Tyne, NE2 4BW, UK;

Correspondence: * corresponding author, A.Maguire{at}ncl.ac.uk


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
It has been suggested that systemic fluoride absorption from drinking water may be influenced by the type of fluoride compound in the water and by water hardness. Using a human double-blind cross-over trial, we conducted this study to measure cmax, Tmax, and Area Under the Curve (AUC) for plasma F concentration against time, following the ingestion of naturally fluoridated hard and soft waters, artificially fluoridated hard and soft waters, and a reference water. Mean AUC over 0 to 8 hours was 1330, 1440, 1679, 1566, and 1328 ng F•min•mL–1 for naturally fluoridated soft, naturally fluoridated hard, artificially fluoridated soft, artificially fluoridated hard, and reference waters, respectively, with no statistically significant differences among waters for AUC, cmax, or Tmax. Any differences in fluoride bioavailability between drinking waters in which fluoride is present naturally or added artificially, or the waters are hard or soft, were small compared with large within- and between-subject variations in F absorption. Abbreviations used: F, fluoride; AUC, Area under the Curve for plasma F concentration against time; AUC(0-3), Area under the Curve for plasma F concentration against time for 0 to 3 hours following water ingestion; AUC(0-8), Area under the Curve for plasma F concentration against time for 0 to 8 hours following water ingestion; cmax, maximum plasma F concentration corrected for baseline plasma F and dose (i.e., F concentration of individual waters); Tmax, time of cmax.

Key Words: bioavailability • drinking water • fluoride • water hardness.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Fluoride occurs naturally in tap drinking-water supplies in the United Kingdom (UK), at concentrations up to 1.5 milligrams per liter. As a means of reducing the prevalence of dental caries, low F concentrations in drinking-water in selected areas of the UK may be increased to a target concentration of 1 milligram per liter by the addition of hexafluorosilicic acid or its sodium salt. However, most of the evidence relating to the long-term general health effects of F is based on studies of populations living in areas receiving F occurring naturally in water supplies.

A recent systematic review on the health effects of F, conducted by the University of York Centre for Reviews and Dissemination (McDonagh et al., 2000), concluded that "the assessment of natural versus artificial water fluoridation effects is greatly limited due to lack of studies making a comparison". A subsequent MRC Working Group, established to determine what further research was required to improve knowledge on F and health, identified bioavailability of naturally fluoridated water vs. artificially fluoridated water and of hard vs. soft water, as important areas of uncertainty (Medical Research Council, 2002). Higher natural levels of F occur typically (but not exclusively) in hard water, while artificial fluoridation usually involves softer water sources. Water hardness is principally determined by the concentrations of calcium and magnesium ions in water and may be expressed as the equivalent concentration of calcium carbonate. Fluoride is present in water supplies as F ions, due to the almost complete dissociation of the parent F compounds, occurring either naturally (predominantly from minerals such as fluorspar [calcium fluoride]) or added as hexafluorosilicic acid or its sodium salt (Department of the Environment, 1987; Her Majesty’s Government, 1991). The undissociated proportion is between 10–18 and 10–30 of the dissociated F ions over the pH range of 6–9 usually found in water supplies, and when the impact of water hardness on dissociation is included, the proportion of free F ion ranges from 91% for water with very high hardness, to more than 99% for soft water (Jackson et al., 2002). It is thought that the absorption of soluble F from the gut into the bloodstream is essentially complete at approximately 95% (Whitford, 1996). However, it has been suggested that absorption may be influenced by the type of F compound in the water and by the water hardness, with the presence of calcium decreasing uptake of F from the gut into the bloodstream, perhaps through ion-pairing, although the importance of any such effect is unclear (Medical Research Council, 2002). A review of the chemistry and bioavailability aspects of F in drinking-water (Jackson et al., 2002), concluded that, "In terms of chemistry and bioavailability there is absolutely no difference between added and ‘natural’ fluoride", and that, "The effect of major cations—calcium and magnesium (hardness) and sodium—on the chemical speciation and hence bioavailability of fluoride is very small". This review was based on in vitro work and a small number of animal studies. With the exception of mineral water (Trautner and Einwag, 1986) and a dilute sodium fluoride solution (Ekstrand et al.,1994), there have been no human studies reported on the bioavailability of F from tap drinking-waters.

The aim of this study was to compare the bioavailability of fluoride in natural and artificially fluoridated drinking-waters, and soft and hard drinking waters, using a human experimental model.


    MATERIALS & METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Subjects
Ethical approval for the study was obtained from the Newcastle and North Tyneside Local Research Ethics Committee. Thirty-six healthy adults, aged between 20 and 35 yrs, volunteered to take part in the study. Twenty subjects with no history of metabolic disease or acid-base disturbance, and who were not receiving a therapeutic diet, were recruited, having given written informed consent.

The subjects were provided with fluoride-free toothpaste and were asked to avoid using any significant fluoride products one week before, as well as during, the whole six-week experimental period. They were also asked to avoid drinking tea and beer and eating seafood during the washout and experimental periods and were provided with low-fluoride bottled waters (< 0.02 mg F/L) for drinking and cooking.

For the 11 males and nine females who completed all aspects of the study, the mean (± SD) age, weight, height, and body mass index were 25.7 (± 4.5) yrs, 62.7 (± 12.1) kg, 163.1 (± 9.0) cm, and 23.3 (± 2.3) kg/m2, respectively, for females, and 25.4 (± 2.5) yrs, 75.5 (± 6.2) kg, 175.8 (± 6.3) cm, and 24.5 (± 2.4) kg/m2 for males.

Experimental Design
The study was a human experimental double-blind cross-over trial, comparing observations within individuals. Over the six-week experimental period, each subject underwent 5 experimental sessions, with a different water consumed on each session and an interval of approximately one week between sessions. Test and reference waters were allocated randomly to the 5 experimental sessions by the project statistician. The test drinking waters were:

  • artificially fluoridated soft tap water (AFS) containing 1.01 mg F/L and 50 mg CaCO3/L,
  • artificially fluoridated hard tap water (AFH) containing 0.97 mg F/L and 382 mg CaCO3/L,
  • naturally fluoridated soft bottled water (NFS) containing 1.06 mg F/L and 63 mg CaCO3/L, and
  • naturally fluoridated hard tap water (NFH) containing 0.91 mg F/L and 381 mg CaCO3/L.
  • The reference water (REF) was Water for Irrigation BP (British Pharmacopoeia BP) with sodium fluoride added, containing 1.02 mg F/L and 3 mg CaCO3/L (Pharmacy Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK).

All test waters came from UK tap water supplies apart from NFS, which was an Italian mineral water (Acqua Panna, Tione Spring, Italy, bottled by Panna SpA, Italy).

Sample Collection
After an overnight fast, a forearm vein of each subject was cannulated, and a 5-mL blood sample was taken at baseline (T0). Following the subject’s ingestion of 500 mL of test or reference water at room temperature, a further 11 blood samples were collected at regular intervals over the next 8 hrs.

During each session, each subject consumed a specified low-F drink, meal, and snack at 11.00, 12.00, and 15.00 hours, respectively (fluoride content per serving was 10 µg F, < 10 µg F, and < 1 µg F, respectively). The same food and drink items were consumed in each of the 5 sessions.

Analytical Procedure
Fluoride concentrations in plasma (ng/mL) were measured by means of a F-ion-selective electrode and the "Known Addition-Slope Determination Technique" (Ekstrand, 1977; Ekstrand et al., 1977). Fluoride concentrations in foods were measured with a F-ion-selective electrode after acid diffusion with hexamethyldisiloxane (HMDS), as described by Venkateswarlu (1992) and modified by Zohouri and Rugg-Gunn (1999).

The validity and reliability of the methods used in this study have been tested and described elsewhere (Ekstrand, 1977; Zohouri and Rugg-Gunn, 1999). The Coefficient of Variation (CV%) for the "known addition technique" method used was 9.7%. Results of re-analysis of plasma samples were within 0.64 ng F/mL.

Pharmacokinetic Analysis
To determine the increase in plasma fluoride concentration following consumption of the drinking-water, we derived a "baseline-corrected" plasma fluoride concentration "c" by subtracting the baseline (T0) plasma fluoride concentration from the concentration of fluoride ion found in each plasma sample. This value "c" represented the concentration of fluoride in plasma arising from the fluoride content of the test or reference water. Any negative values for "c" were treated as zero. The area under the plasma fluoride concentration vs. time curve (AUC) from 0 to 3 hrs and 0 to 8 hrs was then calculated.

We "dose-corrected" the AUCs for the F concentration by dividing the AUC value by the concentration of fluoride (mg/L) in the test or reference water, to derive baseline and dose-corrected AUCs for 0–3 and 0–8 hrs, AUC(0-3) and AUC(0-8). In addition, maximum plasma F concentration (cmax) and lag time to maximum F concentration (Tmax) were calculated for each subject for each session.

Statistical Analysis
Following descriptive analysis, the plasma data were analyzed by analysis of covariance with fixed and random effects. The study was treated as a 2-by-2-by-20 factorial design (two types of fluoridation, two levels of hardness, and 20 subjects). Variation between and among subjects was included as a random effect. Type of fluoridation and level of water hardness were fitted as fixed effects. The value of the dependent variable corresponding to the reference water was included as a covariate.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
For the total of 100 experimental sessions undertaken overall by the 20 subjects, the mean baseline fasting plasma concentration of fluoride was 19.76 ng•mL–1 (SD 3.23 ng•mL–1).

Pharmacokinetic variables were determined for each type of drinking water (Table 1Go, Fig.Go): Tmax ranged from 48.0 min for NFH and NFS waters to 51.7 min for AFS water; cmax ranged from 12.5 ng F•mL–1 for NFS water to 15.3 ng F•mL–1 for AFS water; AUC(0-3) ranged from 973 ng F•min•mL–1 (95% CI = 752, 1195) for NFS water to 1217 ng F•min•mL–1 (95% CI = 872, 1562) for AFH water, while AUC(0-8) ranged from 1328 ng F•min•mL–1 (95% CI = 991, 1664) for the REF water to 1679 ng F•min•mL–1 (95% CI = 1284, 2073) for AFS water.


View this table:
[in this window]
[in a new window]

 
Table 1. Pharmacokinetics of Fluoride following Ingestion of 500 mL of Test Water or Reference Water
 

Figure 1
View larger version (18K):
[in this window]
[in a new window]

 
Figure. Estimated baseline-corrected mean plasma F concentration (ng/mL) against time following ingestion of 500 mL of test or reference water (n = 20). Ref, Reference Water; NFS, Naturally Fluoridated Soft Water; AFS, Artificially Fluoridated Soft Water; NFH, Naturally Fluoridated Hard Water; AFH, Artificially Fluoridated Hard Water.

 
Analysis of covariance (Table 2Go) showed that, for Area Under the Curve for 0 to 3 hrs [AUC(0-3)], the mean difference between artificially and naturally fluoridated waters was 176.3 ng F•min•mL–1 (95% CI = –29.9, 382.5), and that between hard and soft waters was 67.5 ng F•min•mL–1 (95% CI = –138.8, 273.7).


View this table:
[in this window]
[in a new window]

 
Table 2. Analysis of Covariance using Pharmacokinetic Parameters in Plasma to Compare Artificially Fluoridated Water, Naturally Fluoridated Water, Hard Water, and Soft Water
 
For Area Under the Curve for 0 to 8 hrs [AUC(0-8)], the mean difference between artificially and naturally fluoridated waters was 237.3 ng F•min•mL–1 (95% CI = –49.7, 524.2), and between hard and soft waters, it was –1.0 ng F•min•mL–1 (95% CI = –288.0, 285.9).

No statistically significant differences between waters for Tmax, cmax, or Area Under the Curve for the periods 0 to 8 and 0 to 3 hrs were detected by analysis of covariance.

A noticeable feature observed in the data was the large variation in fluoride absorption both within and between subjects; there were large differences among subjects and, for individual subjects, there were large differences among the different types of water. For three-hour AUC, the estimated standard deviation of the between-subject random errors, based on the analysis of covariance model, was 166 ng F•min•mL–1; the estimated standard deviation of the within-subject random errors was 470 ng F•min•mL–1. The corresponding figures for eight-hour AUC were 207 and 655 ng F•min•mL–1. Across all 20 subjects, the observed differences between the two types of fluoride and between hard and soft water were not large when considered against these two sources of variation and were not statistically significant.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
This study provides the first data on F pharmacokinetics and bioavailability of F from naturally and artificially fluoridated tap drinking-waters with different degrees of hardness. The results suggest that any differences between waters for these variables are small.

The analytical technique used in this study to measure plasma F concentration has been reported to provide sensitive and reliable determination of F in small volumes of plasma samples (Ekstrand et al., 1977). Since plasma F concentrations are influenced by the relative rates of bone accretion and dissolution, we chose the age range of subjects (21 to 35 yrs) to ensure the inclusion of individuals whose skeletal mass was still increasing. At the same time, the relatively narrow age range selected minimized inter-person variability, thus maximizing the potential of the study to detect treatment-related differences.

The results show similarity in time to reach maximum plasma F concentration for different types of water, which suggests that the rate of F absorption is independent of the type of water with regard to hardness (soft or hard) or fluoride (i.e., artificially or naturally fluoridated).

The relatively wide variations in AUCs for plasma F may have arisen because the subjects were not prevented from moving around during their eight-hour experimental period once the cannula was in place, which may have reduced the rate and extent of gastric emptying, with a resultant impact on F absorption from the stomach. Fluoride absorption from the stomach occurs by simple diffusion of HF, with the rate of absorption dependent upon the concentration gradient of HF and inversely related to the pH of the stomach contents (Whitford, 1990). Absorption from the stomach may account for up to 50% of the amount ingested, with the remainder being absorbed from the upper small intestine (Whitford, 1996).

The mean values for cmax and AUC for artificially fluoridated waters were slightly, but (given the wide 95% Confidence Intervals) not significantly, higher than those for naturally fluoridated waters. Any differences between F bioavailability of these waters are likely to be small.

With regard to water hardness, although the observed mean AUC for the hard waters was slightly higher than that for the soft waters, any differences between F bioavailability of these waters are also small. This is consistent with results from a study involving administration of F simultaneously with a calcium-rich breakfast and calcium-poor lunch in which the calcium content of the food did not influence F bioavailability (Arnold et al., 1989), although other studies have shown the bioavailability of F to be affected when taken with various foods. Foods containing appreciable amounts of divalent or trivalent cations can lead to the formation of insoluble complexes and precipitates that reduce F absorption (Ekstrand and Ehrnebo, 1979; Spak et al., 1982; Whitford, 1996).

Across all 20 subjects, there were two main sources of variation, with large differences in Area Under the Curve between subjects and, for individual subjects, large differences in Area under the Curve among the 5 different waters. The observed differences between the two types of fluoride and between hard and soft waters were not large when considered against these two sources of variation and were not statistically significant.

In young or middle-aged adults, once F is absorbed from the gastro-intestinal tract, approximately 50% is excreted in the urine (World Health Organization, 1994), although this proportion can vary considerably, depending on numerous variables, including F intake, acid-base balance, and urinary pH (Ekstrand et al., 1978; Whitford, 1996). Some of the relatively wide variation in AUCs between subjects observed in this study might be explained by inter-individual differences in physiological variables such as volume and pH of gastric secretions, gastro-intestinal motility, plasma volume, and urinary pH.

This study adds to the understanding of F pharmacokinetics of naturally fluoridated compared with artificially fluoridated waters, and hard compared with soft waters. The findings suggest that, measured by Area under the Curve, Tmax, and cmax following water ingestion, any differences in bioavailability of fluoride between drinking waters in which the fluoride is present naturally or added artificially, or the waters are hard or soft, are small compared with the large within- and between-subject variation in F absorption following ingestion of drinking waters with F concentrations close to 1 part per million.


    ACKNOWLEDGMENTS
 
The authors are most grateful to: Emeritus Professor A.J. Rugg-Gunn for his advice regarding the design of the study; Mr. A. Bruce, Water Quality Scientist at Northumbria Water, for his valuable help and advice; the Severn Trent, Northumbrian, and Anglian water companies for supplying the waters; the sedation nurses and Dr. N. Girdler at the School of Dental Sciences, Newcastle University, for arranging cannulation of subjects; Ms. E. Jackson for help in laboratory analyses of the samples; and the study volunteers for their participation and cooperation. This work was undertaken by the University of Newcastle (Faculty of Medical Sciences), which received funding from the Department of Health (# 0290049). The views expressed in the publication are those of the authors and not necessarily those of the Department of Health.

Received for publication June 20, 2004. Revision received April 21, 2005. Accepted for publication September 15, 2005.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS & METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  • Arnold P, Wermeille M, Chapuy MC, Biollaz J, Grandjean EM, Schelling JL, et al. (1989). Influence of food and antacid administration on fluoride bioavailability from enteric-coated sodium fluoride tablets. Bone 10:401–407.
  • Department of the Environment (1987). Code of practice on technical aspects of fluoridation of water supplies. London: HMSO.
  • Ekstrand J (1977). A micromethod for the determination of fluoride in blood plasma and saliva. Calcif Tissue Res 23:225–228.[Medline] [Order article via Infotrieve]
  • Ekstrand J, Ehrnebo M (1979). Influence of milk products on fluoride bioavailability in man. Eur J Clin Pharmacol 16:211–215.[Medline] [Order article via Infotrieve]
  • Ekstrand J, Alvan G, Boréus LO, Norlin A (1977). Pharmacokinetics of fluoride in man after single and multiple oral doses. Eur J Clin Pharmacol 12:311–317.[Medline] [Order article via Infotrieve]
  • Ekstrand J, Ehrnebo M, Boréus LO (1978). Fluoride bioavailability after intravenous and oral administration: importance of renal clearance and urine flow. Clin Pharmacol Ther 23:329–337.[Medline] [Order article via Infotrieve]
  • Ekstrand J, Fomon SJ, Ziegler EE, Nelson SE (1994). Fluoride pharmacokinetics in infancy. Pediatr Res 35:157–163.[Medline] [Order article via Infotrieve]
  • Her Majesty’s Government (1991). Water Industry Act 1991. London: HMSO.
  • Jackson PJ, Harvey PW, Young WF (2002). Chemistry and bioavailability aspects of fluoride in drinking-water. Report No. CO5037. WRc-NSF Ltd, Henley Road, Medenham, Marlow, Bucks, SL7 2HD, pp. 5–9, 27.
  • McDonagh M, Whiting P, Bradley M, Cooper J, Sutton A, Chestnutt I, et al. (2000). A systematic review of public water fluoridation. University of York: NHS Centre for Reviews and Dissemination, pp. 64–66.
  • Medical Research Council (2002). MRC Working Group report on: Water fluoridation and health. London: MRC, pp. 11–17.
  • Spak CJ, Ekstrand J, Zylberstein D (1982). Bioavailability of fluoride added to baby formula and milk. Caries Res 16:249–256.[Medline] [Order article via Infotrieve]
  • Trautner K, Einwag J (1986). Bioavailability of fluoride from some health food products in man. Caries Res 20:518–524.[Medline] [Order article via Infotrieve]
  • Venkateswarlu P (1992). Separation of fluoride from fluoroelastomers by diffusion in test tubes. Anal Chem 64:346–349.[Medline] [Order article via Infotrieve]
  • Whitford GM (1990). The physiological and toxicological characteristics of fluoride. J Dent Res 69(Spec Iss):539–549.
  • Whitford GM (1996). Metabolism and toxicity of fluoride. Basel: Karger. pp 1, 12–15, 46–58.
  • World Health Organization (1994). Fluorides and oral health. Geneva: World Health Organization, pp. 7–9.
  • Zohouri FV, Rugg-Gunn AJ (1999). Fluoride concentration in foods from Iran. Int J Food Sci Nutr 50:265–274.[Medline] [Order article via Infotrieve]

Journal of Dental Research, Vol. 84, No. 11, 989-993 (2005)
DOI: 10.1177/154405910508401104


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Maguire, A.
Right arrow Articles by Moynihan, P.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maguire, A.
Right arrow Articles by Moynihan, P.J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?